What does DJADOUN MEDICAL do?

DJADOUN MEDICAL is a specialist medical practice in Gembloux. Private Limited, started on 17 February 2015.

What is the address of DJADOUN MEDICAL?

The registered office of DJADOUN MEDICAL is located at Rue Saint-Pierre, Bothey 20, 5032 Gembloux.

Is DJADOUN MEDICAL still active?

Yes. According to the CBE (28 September 2026) DJADOUN MEDICAL is active, legal situation “Normale toestand”, started on 17 February 2015.

Is DJADOUN MEDICAL registered on Peppol?

Yes, DJADOUN MEDICAL is registered on the Peppol network with ID 0208:0598731510.

What is the enterprise number of DJADOUN MEDICAL?

The enterprise number of DJADOUN MEDICAL is BE0598731510.

When was DJADOUN MEDICAL founded?

DJADOUN MEDICAL was founded on 17 February 2015.

Who are the directors of DJADOUN MEDICAL?

According to the 2025 annual accounts, the directors of DJADOUN MEDICAL are: SABRINA DJADOUN, SAGANOBA Srl.

Is DJADOUN MEDICAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 February 2015; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DJADOUN MEDICAL make in 2025?

DJADOUN MEDICAL posted a profit after taxes of € 114,202 in financial year 2025.

What is the revenue of DJADOUN MEDICAL?

As a small company, DJADOUN MEDICAL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 160,310.

DJADOUN MEDICAL (Private Limited) - Gembloux

Dossier DJADOUN MEDICAL, printed on 28 September 2026 from databakkes.be/en/0598731510/djadoun-medical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DJADOUN MEDICAL from Gembloux, company number BE0598731510, closed financial year 2025 with a result of € 114,202 after tax. For that financial year DJADOUN MEDICAL recorded a gross margin of € 160,310 and equity of € 20,978. Compared with financial year 2024, the result moved from € 102,068 to € 114,202. Profitable, and profit is growing. The buffer shrank hard: equity is 89 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on January 10, 2026.

What it is worth Shrank hard

€ 20,978

▼ 89% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 114,202

▲ 12% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 131,825

▲ 141% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 278,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 34,136

▼ 22% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 32,695

▼ 24% vs 2024

€ 11,061 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 6,420

▼ 36% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 1,253

▼ 89% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 41,222 Gross margin 2022: € 41,222 First fiscal year in the series	€ 104,845 Gross margin 2023: € 104,845 ▲ 154% vs 2022 (€ 41,222) Favourable step	€ 145,320 Gross margin 2024: € 145,320 ▲ 39% vs 2023 (€ 104,845) Favourable step	€ 160,310 Gross margin 2025: € 160,310 ▲ 10% vs 2024 (€ 145,320) Favourable step	▲ 10%
Profit after taxes	€ 24,687 Profit after taxes 2022: € 24,687 First fiscal year in the series	€ 57,277 Profit after taxes 2023: € 57,277 ▲ 132% vs 2022 (€ 24,687) Favourable step	€ 102,068 Profit after taxes 2024: € 102,068 ▲ 78% vs 2023 (€ 57,277) Favourable step	€ 114,202 Profit after taxes 2025: € 114,202 ▲ 12% vs 2024 (€ 102,068) Favourable step	▲ 12%
Equity	€ 225,430 Equity 2022: € 225,430 First fiscal year in the series	€ 182,707 Equity 2023: € 182,707 ▼ 19% vs 2022 (€ 225,430) Unfavourable step	€ 184,775 Equity 2024: € 184,775 ▲ 1% vs 2023 (€ 182,707) Favourable step	€ 20,978 Equity 2025: € 20,978 ▼ 89% vs 2024 (€ 184,775) Unfavourable step	▼ 89%
Total debts	€ 60,152 Total debts 2022: € 60,152 First fiscal year in the series	€ 174,522 Total debts 2023: € 174,522 ▲ 190% vs 2022 (€ 60,152) Unfavourable step	€ 177,246 Total debts 2024: € 177,246 ▲ 2% vs 2023 (€ 174,522) Unfavourable step	€ 324,630 Total debts 2025: € 324,630 ▲ 83% vs 2024 (€ 177,246) Unfavourable step	▲ 83%
Cash	€ 64,557 Cash 2022: € 64,557 First fiscal year in the series	€ 127,323 Cash 2023: € 127,323 ▲ 97% vs 2022 (€ 64,557) Favourable step	€ 54,741 Cash 2024: € 54,741 ▼ 57% vs 2023 (€ 127,323) Unfavourable step	€ 131,825 Cash 2025: € 131,825 ▲ 141% vs 2024 (€ 54,741) Favourable step	▲ 141%
Retained profit	€ 206,830 Retained profit 2022: € 206,830 First fiscal year in the series	€ 164,107 Retained profit 2023: € 164,107 ▼ 21% vs 2022 (€ 206,830) Unfavourable step	€ 166,175 Retained profit 2024: € 166,175 ▲ 1% vs 2023 (€ 164,107) Favourable step	€ 2,378 Retained profit 2025: € 2,378 ▼ 99% vs 2024 (€ 166,175) Unfavourable step	▼ 99%
Dividend	€ 30,500 Dividend 2022: € 30,500 First fiscal year in the series	€ 100,000 Dividend 2023: € 100,000 ▲ 228% vs 2022 (€ 30,500) Unchanged	€ 100,000 Dividend 2024: € 100,000 Unchanged (€ 100,000) Unchanged	€ 278,000 Dividend 2025: € 278,000 ▲ 178% vs 2024 (€ 100,000) Unchanged	▲ 178%
Bank debt	€ 28,515 Bank debt 2022: € 28,515 First fiscal year in the series	€ 73,626 Bank debt 2023: € 73,626 ▲ 158% vs 2022 (€ 28,515) Unfavourable step	€ 43,263 Bank debt 2024: € 43,263 ▼ 41% vs 2023 (€ 73,626) Favourable step	€ 32,695 Bank debt 2025: € 32,695 ▼ 24% vs 2024 (€ 43,263) Favourable step	▼ 24%
Balance sheet total	€ 285,582 Balance sheet total 2022: € 285,582 First fiscal year in the series	€ 357,229 Balance sheet total 2023: € 357,229 ▲ 25% vs 2022 (€ 285,582) Unchanged	€ 362,021 Balance sheet total 2024: € 362,021 ▲ 1% vs 2023 (€ 357,229) Unchanged	€ 345,608 Balance sheet total 2025: € 345,608 ▼ 5% vs 2024 (€ 362,021) Unchanged	▼ 5%

Key figures of DJADOUN MEDICAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to DJADOUN MEDICAL?

What happened at DJADOUN MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jan 10, 2026 New annual accounts for financial year 2025: profit of € 114,202 (▲ 12% vs 2024). Source: NBB ↗
Feb 17, 2015 Start of the company according to the CBE. KBO

In short

From € 24,687 profit in 2022 to € 114,202 profit in 2025.

Paid € 85,824 in corporate taxes since 2022.

Best year ever: 2025, with € 114,202 profit.

Paid out € 508,500 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DJADOUN MEDICAL? We notify you, reason included.

Follow DJADOUN MEDICAL

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit